These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Yang YA; Tang B; Robinson G; Hennighausen L; Brodie SG; Deng CX; Wakefield LM Cell Growth Differ; 2002 Mar; 13(3):123-30. PubMed ID: 11959813 [TBL] [Abstract][Full Text] [Related]
30. Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines. Pring M; Prime S; Parkinson EK; Paterson I Int J Oncol; 2006 May; 28(5):1279-85. PubMed ID: 16596245 [TBL] [Abstract][Full Text] [Related]
31. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950 [TBL] [Abstract][Full Text] [Related]
32. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1. Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749 [TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability. Zhu S; Goldschmidt-Clermont PJ; Dong C Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161 [TBL] [Abstract][Full Text] [Related]
34. [Epigallocatechin gallate induces apoptosis in human hepatocellular carcinoma HepG2 cells via TGF/Smad signaling pathway]. Tong JL; Nie F; Ran ZH; Pan CQ; Xu XT; Zhu MM; Xiao SD Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):646-50. PubMed ID: 20021857 [TBL] [Abstract][Full Text] [Related]
35. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Jinnin M; Ihn H; Tamaki K Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083 [TBL] [Abstract][Full Text] [Related]
36. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene. Cutroneo KR J Cell Biochem; 2006 Apr; 97(5):933-9. PubMed ID: 16187293 [TBL] [Abstract][Full Text] [Related]
37. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu. Bender H; Wang Z; Schuster N; Krieglstein K J Neurosci Res; 2004 Feb; 75(3):344-52. PubMed ID: 14743447 [TBL] [Abstract][Full Text] [Related]
38. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805 [TBL] [Abstract][Full Text] [Related]
39. Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells. Kim MR; Park DW; Lee JH; Choi DS; Hwang KJ; Ryu HS; Min CK Mol Hum Reprod; 2005 Nov; 11(11):801-8. PubMed ID: 16403803 [TBL] [Abstract][Full Text] [Related]
40. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Ashley DM; Kong FM; Bigner DD; Hale LP Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]